A. Avlami
Impact in
- Molecular Medicine top 5%
- Antibiotic Resistance in Bacteria
Papers in
-
- Antimicrobial Resistance in Staphylococcus 5
- Clostridium difficile and Clostridium perfringens research 2
-
- Bacterial Identification and Susceptibility Testing 9
- Co-authors
- Ioanna Stefanou (3 shared papers)N.J. Legakis (3 shared papers)T. Kordossis (2 shared papers)Nikolaos V. Sipsas (1 shared paper)Alexandra Vasilakopoulou (3 shared papers)G. Petrikkos (5 shared papers)Aristea Velegraki (1 shared paper)Panayotis T. Tassios (4 shared papers)
- Journals
- Clinical Microbiology and Infection (3 papers)Journal of Antimicrobial Chemotherapy (3 papers)Journal of Infection (2 papers)Chemotherapy (2 papers)Journal of Chemotherapy (2 papers)
- Partner nations
- GreeceUnited StatesRussia
In The Last Decade
A. Avlami
22 papers receiving 426 citations
Peers
Comparison fields: 5 of 59
- Molecular Medicine 125
- Applied Microbiology and Biotechnology 20
- Endocrinology 50
- Clinical Biochemistry 62
- Infectious Diseases 140
Countries citing papers authored by A. Avlami
This map shows the geographic impact of A. Avlami's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Avlami with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Avlami more than expected).
Fields of papers citing papers by A. Avlami
This network shows the impact of papers produced by A. Avlami. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Avlami. The network helps show where A. Avlami may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Avlami, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1998 | 84 | |
| 2 | 2001 | 54 | |
| 3 | 2000 | 44 | |
| 4 | 2007 | 44 | |
| 5 | 2003 | 38 | |
| 6 | 2010 | 36 | |
| 7 | 2004 | 32 | |
| 8 | 2000 | 22 | |
| 9 | 2009 | 21 | |
| 10 | 2004 | 16 | |
| 11 | 1986 | 13 | |
| 12 | 2014 | 10 | |
| 13 | 1981 | 8 | |
| 14 | 2004 | 7 | |
| 15 | 1997 | 7 | |
| 16 | 1994 | 7 | |
| 17 | 1999 | 4 | |
| 18 | 2002 | 4 | |
| 19 | 2009 | 3 | |
| 20 | 1981 | 3 |
About A. Avlami
A. Avlami is a scholar working on Infectious Diseases, Clinical Biochemistry, Epidemiology, Molecular Medicine and Public Health, Environmental and Occupational Health, having authored 23 papers that have together received 462 indexed citations. Recurring topics across this work include Bacterial Identification and Susceptibility Testing (9 papers), Antibiotic Resistance in Bacteria (8 papers), Antimicrobial Resistance in Staphylococcus (5 papers), Streptococcal Infections and Treatments (4 papers), Urinary Tract Infections Management (3 papers), Yersinia bacterium, plague, ectoparasites research (3 papers), Helicobacter pylori-related gastroenterology studies (2 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). The work is most often cited by research in Molecular Medicine (125 citations), Applied Microbiology and Biotechnology (20 citations), Endocrinology (50 citations), Clinical Biochemistry (62 citations) and Infectious Diseases (140 citations). A. Avlami has collaborated with scholars based in Greece, United States and Russia. Frequent co-authors include Ioanna Stefanou, N.J. Legakis, T. Kordossis, Nikolaos V. Sipsas, Alexandra Vasilakopoulou, G. Petrikkos, Aristea Velegraki, Panayotis T. Tassios, Alkiviadis Vatopoulos and Anastasia Samakovli. Their work appears in journals such as Clinical Microbiology and Infection, Journal of Antimicrobial Chemotherapy, Journal of Infection, Chemotherapy and Journal of Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.